Dr. Javier Crespo | Medicine and Dentistry | Best Researcher Award

Dr. Javier Crespo | Medicine and Dentistry | Best Researcher Award

Professor at IDIVAL, Spain

Professor Javier Crespo is a distinguished physician-scientist and academic leader in the field of digestive and liver diseases. Currently a Professor of Medicine at the University of Cantabria and Director of the Translational Research in Digestive Pathology group at IDIVAL, he has made significant contributions through over 400 original publications, more than 120 clinical trials, and leadership in numerous national and international research projects. With an H-index of 70 and over 30,000 citations, his work has had a profound global impact. He has played a pivotal role in national health strategies, including Spain’s Hepatitis C elimination plan, and served as President of major professional societies such as SEPD. A mentor to numerous doctoral and master’s students, he has also received multiple prestigious awards for his contributions to medicine and research. His leadership at Marqués de Valdecilla University Hospital earned repeated national recognition for excellence in digestive and hepatitis care.

Professional Profile 

Google Scholar
Scopus Profile
ORCID Profile 

Education

Professor Javier Crespo earned his Degree in Medicine and General Surgery from the University of Cantabria with an Outstanding qualification. He later obtained his Doctorate in Medicine in 1993, receiving the Extraordinary Doctorate Award for academic excellence. His formal education laid a strong foundation for a career marked by clinical rigor and academic depth. In addition to his medical qualifications, he has been accredited as a Professor by ANECA (the Spanish National Agency for Quality Assessment and Accreditation). His academic journey reflects not only excellence in performance but also an enduring commitment to scientific learning and advancement. His scholarly trajectory is rooted in a lifelong dedication to the field of hepatology and digestive pathology, with an early focus on merging basic medical science with clinical research. These formative years have played a crucial role in shaping his influential career in medicine, teaching, and research.

Professional Experience

Professor Crespo has held several prestigious positions throughout his career. He is a Professor of Medicine at the University of Cantabria and Director of the Translational Research in Digestive Pathology group at IDIVAL. He served as Head of the Digestive Service at Marqués de Valdecilla University Hospital from 2010 to 2024. Additionally, he has played strategic roles in healthcare governance, including being a member of Spain’s National Strategic Plan against Hepatitis C since 2015 and coordinator of the AEEH National Liver Health Plan Challenge 2032. His leadership extends to professional societies—he served as President of the Spanish Society of Digestive Pathology (SEPD), President of the National Digestive Commission, and Secretary of the Spanish Association for the Study of the Liver. His professional career reflects a unique blend of clinical excellence, policy leadership, academic mentoring, and research management, making him one of the most respected figures in his specialty.

Research Interest

Professor Crespo’s primary research interests center around digestive and liver diseases, with a particular focus on hepatitis C, liver cirrhosis, and inflammatory bowel diseases. He has led more than 120 clinical trials across Phases I–III and participated in 15 national and 8 international competitive research projects. His translational approach bridges laboratory findings with clinical application, especially in hepatology. Under his leadership, the IDIVAL research group has produced high-impact findings in digestive pathology and liver disease progression. He has authored over 400 original scientific articles, with a strong presence in high-impact journals. His work is cited more than 30,000 times, and he holds an H-index of 70, underscoring his global influence. He is also actively involved in supervising doctoral and postgraduate theses, reflecting his dedication to advancing the next generation of researchers in gastroenterology. His research has contributed significantly to public health, particularly in the management and elimination of hepatitis C.

Award and Honor

Professor Javier Crespo has received numerous national and international awards that recognize both his scientific excellence and public health impact. Among his most prestigious accolades are the Elimination Champions 2023 International Award, granted by the Coalition for Global Hepatitis Elimination, and the International Award at the VI LIFE Forum for HCV Elimination in Lima (2024). Nationally, he has been honored with the Commendation of the Civil Order of Health, the SEPD Gold Medal, and the ACAD Gold Medal. He was also named an Illustrious Torrelaveguense in 2024. Under his leadership, the Digestive Service at Marqués de Valdecilla University Hospital received the Best in Class Award for several consecutive years for excellence in digestive and hepatitis care. His honors reflect not only scientific merit but also his dedication to clinical service and public health leadership, making him one of the most decorated professionals in his field.

Conclusion

In conclusion, Professor Javier Crespo is a highly accomplished and impactful leader in the fields of gastroenterology and hepatology. His career combines outstanding academic achievement, clinical leadership, and translational research excellence. With more than 30,000 citations and an H-index of 70, his scientific contributions have shaped current practices in liver disease treatment and public health strategies. He has held top-level positions in hospitals, universities, research institutes, and national health commissions, evidencing his multifaceted influence. Through his mentorship, he has cultivated a generation of researchers and clinicians, further extending his legacy. His work has not only garnered national and international recognition through prestigious awards but has also led to meaningful improvements in patient care, especially in hepatitis C management. Professor Crespo exemplifies the qualities of a visionary researcher, a compassionate physician, and a dedicated educator—making him exceptionally worthy of recognition such as the Best Researcher Award.

Publications Top Notes

  • Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis

    • Authors: Not listed

    • Year: 2025

    • Citations: 3

  • Letter to the Editor: Optimizing MASLD treatment—A “lead-in phase” before resmetirom

    • Authors: Not listed

    • Year: Not listed

    • Citations: 1

  • Comprehensive Diagnosis of Viral Hepatitis in Spain: Bases for Implementation

    • Authors: Not listed

    • Year: 2025

  • Unraveling MASLD: The Role of Gut Microbiota, Dietary Modulation, and AI-Driven Lifestyle Interventions

    • Authors: Not listed

    • Year: Not listed

    • Citations: 1

  • A multisociety Delphi consensus statement on new fatty liver disease nomenclature

    • Authors: ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, …

    • Year: 2023

    • Citations: 4,096

  • Host recognition of bacterial muramyl dipeptide mediated through NOD2: implications for Crohn’s disease

    • Authors: N Inohara, Y Ogura, A Fontalba, O Gutierrez, F Pons, J Crespo, K Fukase, …

    • Year: 2003

    • Citations: 2,245

  • Modeling NAFLD disease burden in 8 countries (2016–2030)

    • Authors: C Estes, QM Anstee, MT Arias-Loste, H Bantel, S Bellentani, J Caballeria, …

    • Year: 2018

    • Citations: 2,027

  • A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

    • Authors: HSA Newsome, PN Buchholtz, K Cusi, M Linder, T Okanoue, V Ratziu, S Sanyal, …

    • Year: 2021

    • Citations: 1,673

  • Obeticholic acid for the treatment of NASH: Phase 3 trial analysis

    • Authors: ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, …

    • Year: 2019

    • Citations: 1,286

  • Elafibranor resolves NASH without fibrosis worsening

    • Authors: SA Ratziu, V Harrison, S Francque, P Bedossa, P Lehert, L Serfaty, …

    • Year: 2016

    • Citations: 1,217

  • Sofosbuvir and ribavirin in HCV genotypes 2 and 3

    • Authors: ER Zeuzem, S Dusheiko, GM Salupere, R Mangia, A Flisiak, RH Hyland, …

    • Year: 2014

    • Citations: 1,048

  • A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis

    • Authors: Not listed

    • Year: 2024

    • Citations: 983

  • Gene expression of TNF-α and TNF receptors in NASH patients

    • Authors: J Crespo, A Cayón, P Fernández‐Gil, M Hernández‐Guerra, M Mayorga, …

    • Year: 2001

    • Citations: 971

  • Advancing the global public health agenda for NAFLD: Consensus statement

    • Authors: JV Lazarus, HE Mark, QM Anstee, JP Arab, RL Batterham, L Castera, …

    • Year: 2022

    • Citations: 683

Vasileios Alexandros Karakousis | Medicine and Dentistry | Best Researcher Award

Dr. Vasileios Alexandros Karakousis | Medicine and Dentistry | Best Researcher Award

Surgery at Aristotle University of Thessaloniki, Greece

Dr. Vasileios Alexandros Karakousis is a multidisciplinary medical professional with dual degrees in Medicine (MD) and Pharmacy (PharmD), complemented by a Master’s in Clinical and Industrial Pharmacology. He is currently a PhD researcher in Plastic Surgery at the Aristotle University of Thessaloniki and teaches in the postgraduate MSc program in Colorectal Surgery at the University of Thessaly. His research portfolio includes over a dozen peer-reviewed publications in high-impact journals, covering areas such as oncology, immunotherapy, diagnostic imaging, and surgical outcomes. He has also presented at major international conferences across Europe. With clinical training in top hospitals in Greece and France, and fluency in English and French, Dr. Karakousis brings a global perspective to his work. His recent research momentum, coupled with academic and teaching contributions, positions him as a promising early-career researcher making impactful strides in medical science and healthcare.

Professional Profile 

Scopus Profile
ORCID Profile 

Education

Dr. Vasileios Alexandros Karakousis holds an impressive academic background with dual professional degrees. He earned his Doctor of Pharmacy (PharmD) in 2010 and his Doctor of Medicine (MD) in 2017 from the Aristotle University of Thessaloniki (AUTH). He further completed a Master of Science (MSc) in Clinical and Industrial Pharmacology, with a focus on Clinical Toxicology, also from AUTH. Currently, he is pursuing a PhD in Plastic Surgery at Papageorgiou General Hospital, under AUTH’s School of Medicine. His education also includes a European academic exchange through the Erasmus+ Program at Université de Paris. He holds both medical and pharmaceutical licenses from relevant Greek professional bodies. Dr. Karakousis is also multilingual, with certifications in English (C2, University of Michigan) and French (B2, DELF), which enhance his ability to collaborate internationally. His continuous academic development reflects a strong commitment to both scientific inquiry and clinical excellence.

Professional Experience

Dr. Karakousis has cultivated a dynamic professional career across medical, pharmaceutical, and academic domains. He currently teaches in the postgraduate MSc program in Colorectal Surgery at the University of Thessaly, where he contributes to the academic development of future surgeons. His clinical experience spans several prestigious institutions, including AHEPA University Hospital, Ippokrateio Hospital, and hospitals in Paris through externships at Hôpital Saint-Louis and Hôpital Paris Saint-Joseph. His earlier work includes service as a pharmacist in community pharmacies and military medical service at Greek military hospitals. He has also completed a surgical internship and practical training in both hospital and community pharmacy settings. This breadth of experience has shaped him into a well-rounded clinician and academic, capable of bridging pharmaceutical knowledge with surgical and medical practice. His active engagement in multiple clinical environments enhances his ability to apply research insights directly into patient care.

Research Interest

Dr. Karakousis has a broad and evolving set of research interests focused primarily on oncology, surgery, immunology, pharmacology, and diagnostic imaging. His recent research includes systematic reviews, meta-analyses, and case studies in gastrointestinal stromal tumors, medullary thyroid carcinoma, and metastatic colorectal cancer, emphasizing clinical relevance and evidence-based care. He has shown particular interest in cancer immunotherapy, mRNA vaccines, and tumor microenvironment modulation, indicating a forward-looking approach to precision medicine. His work on metaplastic and neuroendocrine breast cancers, as well as rare tumor types, reflects a commitment to addressing under-researched clinical challenges. Additionally, his contributions to diagnostic methodology, such as PET-CT and MRI-endosonography, highlight a keen interest in enhancing preoperative assessment and surgical planning. His multidisciplinary background enables him to pursue translational research that connects pharmacological principles with surgical outcomes and immunological mechanisms, making his academic pursuits both innovative and clinically grounded.

Award and Honor

Dr. Vasileios Alexandros Karakousis has earned recognition through multiple academic and professional achievements, although formal awards are not extensively detailed in the available record. His selection as a presenter at high-level international conferences—including the Joint EWMA-GNEAUPP 2025 Conference in Spain, the 11th Conference of ESES in Turkey, and the 16th Greek-Cypriot Surgical Congress in Cyprus—reflects peer acknowledgment of the quality and significance of his research. He was also a featured presenter at the Scientific Conference of Greek Medical Students, demonstrating early engagement with academic excellence. His role as a lecturer in a postgraduate surgical program further indicates institutional recognition of his expertise. Though not explicitly listed, his numerous peer-reviewed publications in high-impact journals and international collaborations suggest growing influence and respect in the medical research community. These achievements collectively support his eligibility for further awards, including the Best Researcher Award nomination.

Conclusion

Dr. Vasileios Alexandros Karakousis exemplifies the qualities of a promising, multidisciplinary medical researcher. With a robust academic foundation in both medicine and pharmacy, he combines clinical expertise with scientific rigor. His professional journey includes hands-on roles in pharmacy, surgery, teaching, and international externships, highlighting his versatility and dedication to improving healthcare. His recent surge in impactful research—covering oncology, diagnostics, pharmacology, and immunotherapy—demonstrates a forward-thinking, evidence-based approach that resonates with current global healthcare priorities. As a multilingual academic with international experience, he is well-positioned for collaboration and leadership in cross-border research initiatives. While his career is still in a growth phase, his academic trajectory, research contributions, and teaching involvement underscore his potential to make lasting contributions to medical science. Based on his achievements and promise, Dr. Karakousis is a compelling candidate for recognition such as the World Top Scientists Best Researcher Award.

Publications Top Notes

  • Multifocal Gastrointestinal Stromal Tumors (GISTs) of the Small Intestine in Patients with Neurofibromatosis Type 1 (NF-1): Meta‑Analysis and Systematic Review of the Literature

    • Authors: Stylianos Mantalovas; Vasileios Alexandros Karakousis; Christina Sevva; Panagiota Roulia; Stavros Savvakis; Georgios Anthimidis; Konstantinos Papadopoulos; Vasiliki Magra; Nikolaos Varsamis; Christoforos S. Kosmidis; et al.

    • Year: 2025

  • The Efficacy of Positron Emission Tomography/Computed Tomography Scan (PET CT) in the Diagnosis of Local Recurrence and Metastases in Surgical Patients with Medullary Thyroid Carcinoma: A Systematic Review and Meta‑Analysis of the Last 5 Years (2020–2024)

    • Authors: Konstantinos Papadopoulos; Ioannis Iakovou; Stylianos Mantalovas; Christoforos S. Kosmidis; Stiliani Laskou; Vasileios Alexandros Karakousis; Christina Sevva; Marios Dagher; Panagiota Roulia; Ismini Kountouri; et al.

    • Year: 2024

  • Streamline Flow of the Portal Vein Affects the Distribution of Colorectal Cancer Metastases: Clinical Reality or Just a Belief? A Systematic Review and Meta‑Analysis

    • Authors: Stavros Savvakis; Vasileios I. Lagopoulos; Stylianos Mantalovas; Eleni Paschou; Periklis Kopsidas; Christina Sevva; Alexandros Vasileios Karakousis; Eleni Gigi; Isaak Kesisoglou

    • Year: 2024

  • A 78‑Year‑Old Man with Elastofibroma Dorsi Presenting as a Left Subscapular Mass

    • Authors: Christoforos S. Kosmidis; Konstantinos Vlassopoulos; Chrysi Maria Mystakidou; Vasiliki Theodorou; Alexandros Vasileios Karakousis; Nikolaos Iason Katsios; Fedra Louloudopoulou; Anna Andreadi; Paris Pentousis; Stylianos Mantalovas; et al.

    • Year: 2024

  • Neuroendocrine Breast Carcinoma: Interesting Images of an Underdiagnosed Entity

    • Authors: Christoforos Kosmidis; Kassiani Boulogeorgou; Panagiota ___; Marios Dagher; Georgios Anthimidis; Georgios Petrakis; Charilaos Koulouris; Stylianos Mantalovas; Styliani Laskou; Vasiliki Magra; et al.

    • Year: 2024

  • Immune‑Specific and Tumor‑Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy

    • Authors: Theodora Katopodi; Savvas Petanidis; Eirini Grigoriadou; Doxakis Anestakis; Charalampos Charalampidis; Ioanna P. Chatziprodromidou; George Floros; Panagiotis Eskitzis; Paul Zarogoulidis; Charilaos Koulouris; et al. (includes V. A. Karakousis)

    • Year: 2024

  • Metaplastic Breast Carcinoma – A Rare Subtype of Breast Cancer that Poses a Challenge to Treatment: 2 Case Reports and Review of the Literature

    • Authors: Vasiliki Magra; Sofia Baka; Eleni Georgakoudi; Vasiliki Theodorou; Chrysi Maria Mystakidou; Evanthia Papadopoulou; Alexandros Karakousis; Petrina Miltiadous; Georgios Anthimidis; Christoforos Kosmidis

    • Year: 2024

  • Tumor Cell Metabolic Reprogramming and Hypoxic Immunosuppression: Driving Carcinogenesis to Metastatic Colonization

    • Authors: Theodora Katopodi; Savvas Petanidis; Doxakis Anestakis; Charalampos Charalampidis; Ioanna Chatziprodromidou; George Floros; Panagiotis Eskitzis; Paul Zarogoulidis; Charilaos Koulouris; Christina Sevva; et al.

    • Year: 2024

  • Acute Gangrenous Appendicitis in a 70‑Year‑Old Patient with Multiple Myeloma

    • Authors: (Not fully listed); Vasileios Alexandros Karakousis included.

    • Year: 2024

  • Preoperative Assessment of Perianal Fistulas with Combined Magnetic Resonance and Three-Dimensional Endoanal Ultrasound: A Prospective Study

    • Authors: Nikolaos Varsamis; Christoforos Kosmidis; Grigorios Chatzimavroudis; Fani Apostolidou Kiouti; Christoforos Efthymiadis; Vasilis Lalas; Chrysi Maria Mystakidou; Christina Sevva; Konstantinos Papadopoulos; Georgios Anthimidis; et al.

    • Year: 2023

  • Immunohistochemical Femoral Nerve Study Following Bisphosphonates Administration

    • Authors: Vasileios Alexandros Karakousis; Danai Liouliou; Aikaterini Loula; Nikoleta Kagianni; Eva‑Maria Dietrich; Soultana Meditskou; Antonia Sioga; Theodora Papamitsou

    • Year: 2020

  • Potential Drug–Drug Interactions in Prescriptions Dispensed in Community Pharmacies in Greece

    • Authors: Anna Chatsisvili; Ioakeim Sapounidis; Georgia Pavlidou; Eudoxia Zoumpouridou; Vasileios‑Alexandros Karakousis; Marios Spanakis; Lefteris Teperikidis; Ioannis Niopas

    • Year: 2010

Stephen Higgins | Medicine and Dentistry | Best Researcher Award

Dr. Stephen Higgins | Medicine and Dentistry | Best Researcher Award

Surgical Resident at Nebraska Medicine, United States

Dr. Stephen E. Higgins Jr., DMD, MPH, is an accomplished clinician and academician currently pursuing his M.D. at the University of Nebraska College of Medicine, with an expected graduation date of May 2025. He is a resident in Oral and Maxillofacial Surgery at the University of Nebraska Medical Center and Creighton University School of Dentistry. Dr. Higgins combines extensive training in dentistry, medicine, and public health to provide interdisciplinary insights into surgical and public health challenges. Known for his academic rigor and leadership, he serves as a Clinical Instructor at Creighton University and actively contributes to academic and clinical teaching. His commitment to excellence is reflected in his numerous presentations, scholarly publications, and leadership roles within national medical and dental organizations. Dr. Higgins is especially noted for his dynamic involvement in both clinical care and scientific research, aiming to integrate cutting-edge research with clinical practice. With more than a decade of progressive academic and research experience, Dr. Higgins stands out as a dedicated scholar, committed to improving patient care and advancing medical knowledge. His work reflects a balance of clinical expertise, teaching, and research that positions him as a future leader in oral and maxillofacial surgery.

Professional Profile

Education

Dr. Higgins has pursued a diverse and intensive academic path, integrating dentistry, medicine, and public health. He earned his Doctor of Dental Medicine (D.M.D.) degree from the University of New England College of Dental Medicine in 2022, where he also received multiple commendations for academic excellence and leadership. He holds a Master of Public Health (M.P.H.) from the University of Massachusetts Amherst, completed in 2018, where he developed a strong foundation in epidemiology, biostatistics, and health systems research. He is currently a candidate for a Doctor of Medicine (M.D.) degree at the University of Nebraska College of Medicine, scheduled to graduate in 2025. His academic journey began with a Bachelor of Science in Biology from Providence College in 2012, complemented by a minor in Business Studies. Dr. Higgins also completed a post-baccalaureate program at Worcester State University, graduating in 2016. His academic foundation has been enhanced by strong performance and honors, such as his induction into Phi Kappa Phi Honor Society. This comprehensive educational background uniquely equips Dr. Higgins with an integrated approach to healthcare, enabling him to navigate clinical practice, academic research, and health policy with precision and insight.

Professional Experience

Dr. Higgins’s professional trajectory reflects a blend of clinical practice, academic instruction, and research leadership. Since 2022, he has been training as a resident in Oral and Maxillofacial Surgery at the University of Nebraska Medical Center and Creighton University School of Dentistry. His dual-role residency under esteemed mentors Dr. Valmont Desa and Dr. Terry Lanphier emphasizes complex surgical procedures and interdisciplinary collaboration. Concurrently, he has served as a Clinical Instructor at Creighton University, where he mentors dental students in clinical procedures, case management, and academic development. Prior to his residency, he held leadership positions as President of the Oral and Maxillofacial Surgery Club and Student Representative to the Research Committee at the University of New England. His clinical experience is further strengthened by licensure to practice dentistry in Nebraska, and affiliations with major national bodies including the ADA, AMA, and AAOMS. Throughout his training, Dr. Higgins has demonstrated a strong commitment to integrating patient care with academic inquiry, often taking lead roles in research projects and quality improvement initiatives. His professional experience demonstrates a commitment to excellence, mentorship, and continuous learning in both surgical and academic contexts.

Research Interests

Dr. Higgins has cultivated a broad and evolving portfolio of research interests that span clinical oral surgery, public health, and medical education. His primary research focus includes the evaluation of surgical techniques in oral and maxillofacial surgery, particularly in stability and outcomes following procedures like sagittal split osteotomies. He has explored topics ranging from dentist comfort in diagnosing oral pathology to the impact of antibiotics on gut microbiota, reflecting his interdisciplinary expertise. Dr. Higgins has co-authored multiple peer-reviewed publications and has presented extensively at national conferences, including the Society for Academic Emergency Medicine and the North American Congress of Clinical Toxicology. His early work in emergency medicine explored benchmarking scholarly productivity, while subsequent research examined substance abuse interventions via telemedicine and health referral systems. These interests underscore his commitment to bridging gaps between research, policy, and patient care. By integrating clinical practice with inquiry-driven research, Dr. Higgins aims to advance evidence-based approaches in surgery and healthcare delivery. He continues to develop research that is translational in nature, driven by real-world clinical challenges and guided by rigorous academic methodologies.

Awards and Honors

Dr. Higgins has received numerous awards and recognitions throughout his academic and professional career, underscoring his excellence in leadership, research, and academic performance. While pursuing his D.M.D. at the University of New England, he was awarded the prestigious AAOMS Dental Student Award, recognizing exceptional promise in oral and maxillofacial surgery. He consistently earned Letters of Commendation for four consecutive years, reflecting his high academic performance and dedication. He graduated with Honors Research Distinction, highlighting his scholarly contributions to oral health research. He also received a Student Leadership Certificate for his active engagement in student organizations and advocacy. During his earlier academic career, Dr. Higgins was inducted into the Phi Kappa Phi Honor Society at Worcester State University, a distinction reserved for students of the highest academic caliber. These accolades reflect not only Dr. Higgins’s intellectual aptitude but also his capacity for leadership, initiative, and service. His ongoing involvement with national professional organizations such as the ADA, AMA, and AAOMS further reflects his commitment to the highest standards of clinical practice and professional development. These honors validate Dr. Higgins’s standing as a promising figure in academic medicine and surgery.

Conclusion

Dr. Stephen E. Higgins Jr. is a highly promising and accomplished early-career researcher whose interdisciplinary background and active research involvement make him a strong candidate for the Best Researcher Award. His combination of clinical training, research leadership, and publication record reflects a deep commitment to advancing evidence-based practices in oral and maxillofacial surgery and public health.

While he is still building his publication portfolio and academic footprint, the trajectory and potential for impact are clearly evident. If the award committee values early-career excellence, breadth of contribution, and leadership, Dr. Higgins would be a very deserving recipient.

Publications Top Notes

  • Authors: Stephen E. Higgins Jr., Valmont Desa

  • Year: 2025

  • Title: Comparing the Infection Rates of Strut Versus Straight Plates in Sagittal Split Osteotomies

  • Journal: Journal of Oral and Maxillofacial Surgery

  • DOI: 10.1016/j.joms.2025.03.001

  • Citation: Higgins, S.E. Jr., & Desa, V. (2025). Comparing the infection rates of strut versus straight plates in sagittal split osteotomies. Journal of Oral and Maxillofacial Surgery. https://doi.org/10.1016/j.joms.2025.03.001

 

  • Authors: Edwin D. Boudreaux, Stephen E. Higgins Jr., Rebecca Reznik-Zellen, Bo Wang, Gregory Volturo

  • Year: 2019

  • Title: Scholarly Productivity and Impact: Developing a Quantifiable, Norm-Based Benchmarking Methodology for Academic Emergency Medicine

  • Journal: Academic Emergency Medicine, Volume 26, Issue 6, Pages 594–604

  • DOI: 10.1111/acem.13704

  • Citation: Boudreaux, E.D., Higgins, S.E., Reznik-Zellen, R., Wang, B., & Volturo, G. (2019). Scholarly productivity and impact: Developing a quantifiable, norm-based benchmarking methodology for academic emergency medicine. Academic Emergency Medicine, 26(6), 594–604. https://doi.org/10.1111/acem.13704